Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Kai Su

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF SignalingYu-Kai Su, Oluwaseun Adebayo Bamodu, I-Chang Su, et al.
Nanomedicine (London, England)|August 23, 2023
Nanodiamonds-in-oil emulsions elicit potent immune responses for effective vaccination and therapeuticsHsin-Hung Lin, Chih-Yen Wang, Feng-Jen Hsieh, et al.
Journal of Clinical Medicine|July 5, 2019
Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated MacrophagesHao-Yu Chuang, Yu-Kai Su, Heng-Wei Liu, et al.
Cancers|December 1, 2019
Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in <i>STAT3/5A</i>-Addicted GlioblastomaHeng-Wei Liu, Peter Mingjui Lee, Oluwaseun Adebayo Bamodu, et al.
Biomedicines|July 27, 2022
Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in GlioblastomaI-Chang Su, Yu-Kai Su, Hao-Yu Chuang, et al.
Journal of Ethnopharmacology|June 13, 2017
Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expressionYu-Kai Su, Ping-Hsiao Shih, Wei-Hwa Lee, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|October 4, 2024
Age- and gender-dependent impact of titanium vertebral augmentation implants combined with cementing on subsequent vertebral fracture incidence: A comparative study with cementing aloneChien-Ting Sun, Yi-Shan Yang, Chen-Ling Lan, et al.
Prostate International|March 30, 2017
Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancerElton Llukani, Benjamin F Katz, Ilir Agalliu, et al.
Cancers|December 20, 2018
The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In VivoHeng-Wei Liu, Yu-Kai Su, Oluwaseun Adebayo Bamodu, et al.
Oncotarget|August 27, 2016
Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypesLi Wei, Yu-Kai Su, Chien-Min Lin, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Combined Treatment with Acalabrutinib and Rapamycin Inhibits Glioma Stem Cells and Promotes Vascular Normalization by Downregulating BTK/mTOR/VEGF SignalingYu-Kai Su, Oluwaseun Adebayo Bamodu, I-Chang Su, et al.
Nanomedicine (London, England)|August 23, 2023
Nanodiamonds-in-oil emulsions elicit potent immune responses for effective vaccination and therapeuticsHsin-Hung Lin, Chih-Yen Wang, Feng-Jen Hsieh, et al.
Journal of Clinical Medicine|July 5, 2019
Preclinical Evidence of STAT3 Inhibitor Pacritinib Overcoming Temozolomide Resistance via Downregulating miR-21-Enriched Exosomes from M2 Glioblastoma-Associated MacrophagesHao-Yu Chuang, Yu-Kai Su, Heng-Wei Liu, et al.
Cancers|December 1, 2019
Enhanced Hsa-miR-181d/p-STAT3 and Hsa-miR-181d/p-STAT5A Ratios Mediate the Anticancer Effect of Garcinol in <i>STAT3/5A</i>-Addicted GlioblastomaHeng-Wei Liu, Peter Mingjui Lee, Oluwaseun Adebayo Bamodu, et al.
Biomedicines|July 27, 2022
Ubiquitin-Specific Protease 6 n-Terminal-like Protein (USP6NL) and the Epidermal Growth Factor Receptor (EGFR) Signaling Axis Regulates Ubiquitin-Mediated DNA Repair and Temozolomide-Resistance in GlioblastomaI-Chang Su, Yu-Kai Su, Hao-Yu Chuang, et al.
Journal of Ethnopharmacology|June 13, 2017
Antrodia cinnamomea sensitizes radio-/chemo-therapy of cancer stem-like cells by modulating microRNA expressionYu-Kai Su, Ping-Hsiao Shih, Wei-Hwa Lee, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|October 4, 2024
Age- and gender-dependent impact of titanium vertebral augmentation implants combined with cementing on subsequent vertebral fracture incidence: A comparative study with cementing aloneChien-Ting Sun, Yi-Shan Yang, Chen-Ling Lan, et al.
Prostate International|March 30, 2017
Low levels of serum testosterone in middle-aged men impact pathological features of prostate cancerElton Llukani, Benjamin F Katz, Ilir Agalliu, et al.
Cancers|December 20, 2018
The Disruption of the β-Catenin/TCF-1/STAT3 Signaling Axis by 4-Acetylantroquinonol B Inhibits the Tumorigenesis and Cancer Stem-Cell-Like Properties of Glioblastoma Cells, In Vitro and In VivoHeng-Wei Liu, Yu-Kai Su, Oluwaseun Adebayo Bamodu, et al.
Oncotarget|August 27, 2016
Preclinical investigation of ibrutinib, a Bruton's kinase tyrosine (Btk) inhibitor, in suppressing glioma tumorigenesis and stem cell phenotypesLi Wei, Yu-Kai Su, Chien-Min Lin, et al.
Pageof 5